The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
NCT05312151 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2025-06-13
Summary
The Safety and Tolerability of COMP360 in Participants with Post-traumatic Stress Disorder
Conditions
- Post Traumatic Stress Disorder
Interventions
- DRUG
-
Open label
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-10
- Primary Completion
- 2024-02-12
- Completion
- 2024-02-12
- FDA Drug
- Yes
Countries
- United States
- United Kingdom
Study Locations
More Related Trials
-
A Study of Psilocybin for PTSD
NCT06407635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Mindfulness-based Psilocybin Therapy for PTSD
NCT07104916 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Sleep-directed Hypnosis As A Complement To Cognitive Processing Therapy (CPT) In Treating Posttraumatic Stress Disorder (PTSD)
NCT00725192 ·Status: UNKNOWN ·Phase: NA
-
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD
NCT07275970 ·Status: RECRUITING ·Phase: PHASE1
-
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
NCT05554094 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treatment of Post Traumatic Stress Disorder in Patients With Other Mental Illnesses
NCT00053690 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation Plus Reactivation Therapy Efficacy on PTSD Symptom Severity in Resistant PTSD
NCT06111976 ·Status: RECRUITING ·Phase: NA
-
The Effect of Dual Attention in an EMDR Intervention
NCT05600868 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study to Assess the Use of Methylone in the Treatment of PTSD
NCT05741710 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder
NCT06146049 ·Status: NOT_YET_RECRUITING
-
Neurofeedback for Post-Traumatic Stress Disorder
NCT05123690 ·Status: RECRUITING ·Phase: NA
-
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
NCT06885996 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD
NCT06215261 ·Status: COMPLETED ·Phase: PHASE2
-
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
NCT06989957 ·Status: RECRUITING ·Phase: PHASE1
-
Feasibility of an Intervention for Somatic Flashbacks in PTSD
NCT05996913 ·Status: RECRUITING ·Phase: NA
-
Northwest Therapies Trauma Psilocybin Study Compassionate Use Study
NCT05042466 ·Status: UNKNOWN ·Phase: PHASE1
-
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
NCT06902974 ·Status: RECRUITING ·Phase: PHASE2
-
The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.
NCT06993662 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Post-Traumatic Stress Disorder (PTSD) and Seroquel
NCT01066156 ·Status: COMPLETED ·Phase: NA
-
A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD
NCT04438512 ·Status: NO_LONGER_AVAILABLE
-
Psychobiological Mechanisms of Resilience to Trauma
NCT00069212 ·Status: COMPLETED
-
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
NCT05067244 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JZP150 in Adults With Posttraumatic Stress Disorder
NCT05178316 ·Status: COMPLETED ·Phase: PHASE2
-
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
NCT00383786 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization and Modulation of Traumatic Memories in PTSD Patients Using TMS
NCT06372639 ·Status: COMPLETED ·Phase: NA